Abstract:In this review, we provide a comprehensive overview of the neurochemical systems implicated in depressive disorders and emphasize the need to gain a better understanding in order to develop more effective treatments. Moreover, we present a range of techniques for monitoring neurochemical release, with a particular focus on the recently developed genetically encoded neurochemical sensors. These sensors offer a valuable opportunity to monitor neurochemical dynamics in vivo with high spatial–temporal resolution. Additionally, we delve into recent depression studies that utilized these neurochemical sensors and discuss potential improvements that can be implemented to better meet the specific needs of studying depression. Depressive disorders are a common and debilitating form of mental illness with significant impacts on individuals and society. Despite the high prevalence, the underlying causes and mechanisms of depressive disorders are still poorly understood. Neurochemical systems, including serotonin, norepinephrine, and dopamine, have been implicated in the development and perpetuation of depressive symptoms. Current treatments for depression target these neuromodulator systems, but there is a need for a better understanding of their role in order to develop more effective treatments. Monitoring neurochemical dynamics during depressive symptoms is crucial for gaining a better a understanding of their involvement in depressive disorders. Genetically encoded sensors have emerged recently that offer high spatial–temporal resolution and the ability to monitor neurochemical dynamics in real time. This review explores the neurochemical systems involved in depression and discusses the applications and limitations of current monitoring tools for neurochemical dynamics. It also highlights the potential of genetically encoded sensors for better characterizing neurochemical dynamics in depression‐related behaviors. Furthermore, potential improvements to current sensors are discussed in order to meet the requirements of depression research.

Advances in Optogenetic Studies of Depressive-Like Behaviors and Underlying Neural Circuit Mechanisms

Pushing the Frontiers: Optogenetics for Illuminating the Neural Pathophysiology of Bipolar Disorder

Optogenetics: What It Has Uncovered in Potential Pathways of Depression.

Wiring the depressed brain: optogenetic and chemogenetic circuit interrogation in animal models of depression

Optogenetic and chemogenetic insights into the neurocircuitry of depression‐like behaviour: A systematic review

Key Technologies and Progress of Precision Optogenetics

Progress in understanding mood disorders: optogenetic dissection of neural circuits

Optogenetic Investigation of Neuropsychiatric Diseases

Research Progress on Neural Circuit Mechanisms of Depression

Optogenetic Dissection of Neural Circuits Underlying Stress-Induced Mood Disorders

Molecular Tools and Approaches for Optogenetics

Optogenetics for Understanding and Treating Brain Injury: Advances in the Field and Future Prospects

Repurposing Ketamine in the Therapy of Depression and Depression-Related Disorders: Recent Advances and Future Potential

Optogenetics in neuroscience: what we gain from studies in mammals

Genetically encoded sensors for in vivo detection of neurochemicals relevant to depression

Optogenetic stimulation of ventral tegmental area dopaminergic neurons in a female rodent model of depression: The effect of different stimulation patterns

Optogenetics: a Novel Optical Manipulation Tool for Medical Investigation.

The Roles of Optogenetics and Technology in Neurobiology: A Review

Recent Advances in Cellular Optogenetics for Photomedicine

An entorhinal-visual cortical circuit regulates depression-like behaviors

The recent progress in animal models of depression